Karin Klein

Never stop learning...., especially from top mentors and organizations... After a few years in PE/VC industry, I signed up for the PE/VC course at University of Chicago, organization that currently has itself over USD 3 billion of investments in private equity and venture capital. The course is led by Scott Meadow, who shares his 40+ years of direct investment experience as a principal investor in firms and partner in PE/VC funds. The program is designed by the The University of Chicago Booth School of Business faculty, including Steven Kaplan, most quoted academic expert on how PE and VC funds work, and the author of the Kaplan-Schoar Index (see link in comments), used now as an industry standard, and reported by Preqin and others. The program brings together leaders from around the world, current and future start-up founders, PE/VC professionals, hedge funds and family office managers, and corporate officers acting as LP's. Every time I come to Chicago, I search for newest trends, deep understanding of business issues, but also for energy and inspiration coming from discussions with peers.

276

14 Comments

Capital formation isn’t just about fundraising; it’s about building trust through transparency and clarity. I just wrapped moderating a panel at SVB’s Venture Connect conference, joined by Erlina Yeo Terwelp, Geoff Taylor, Brian Chen, and Stephen Bluestein. The goal: an interactive discussion on how GPs can build enduring partnerships with LPs in today’s fundraising environment. Key themes and takeaways from the conversation: • Relationships are paramount: Provide access to multiple investment team members across levels. Authentic, consistent engagement is foundational to long-term partnerships.  • Show your fund math: LPs want to see how ownership stakes and exit expectations map to net returns—at the actual fund size. Scaling isn’t a strategy unless supported by fundamentals. Help LPs draw clear conclusions. • Transparency builds trust: Be transparent on valuation methods, revenue multiple assumptions, even succession planning. Consistency and openness go a long way. • Investing in venture: LPs are active, but the bar is higher. Two deliverables I’ll be focusing on in our next cycle: 1. Elevating the operations DDQ. Now the second most-viewed item in any data room, right behind the investor deck. 2. Ensuring our deck clearly communicates fund math. From ownership to exit to net DPI—at the fund size we’re marketing. This experience reaffirmed that transparency and trust-building are critical, especially when the fundraising environment is as bifurcated as the markets we’re investing in. Thanks to Silicon Valley Bank, Bobby Donnelly, and Mark Lau for the opportunity, and to everyone who joined the discussion! 

130

4 Comments

Thrilled to announce Greenfield Partners' lead investment in Eleos Health's $60M Series C! From our first meeting with Alon Joffe and team, their vision for transforming behavioral healthcare deeply resonated with us. The challenge is clear: by 2030, we're facing a 4.5M clinician shortage in mental health. What impressed us most was Eleos's practical, innovative approach to this crisis - using AI not to replace clinicians, but to dramatically expand their capacity to deliver care. The results speak for themselves - over 120 healthcare organizations across 30+ states are already seeing documentation time cut in half. But what truly excites me is the road ahead. We're already working closely with the Eleos team under the leadership of our Operating Partner Nir Goldstein, implementing our seven-pillar GTM framework to accelerate their growth with efficiency. To Alon Joffe, Dror Zaide, Alon Rabinovich, and the entire Eleos team - congratulations on this milestone! The behavioral health space needs your innovation now more than ever, and we at Greenfield couldn't be more excited to partner with you on this journey. Looking forward to supporting your mission of empowering clinicians to focus on what matters most - delivering exceptional patient care. Itay Inbar, Nir Goldstein

178

9 Comments

I spoke with Christien Louviere of BDE Capital about his journey from a $330mm exit to becoming an independent sponsor. Christien shared excellent insights for folks looking to partner with business owners, rather than buy sellers out completely. Below are a few of the topics we covered: - Why he moved from “zero-to-one” startups to a buy-then-build strategy - How Christien's background shaped a focus on growth vs. cost-cutting - Why 20–40% rolled equity is central to his deal structures—and how it builds trust with sellers - Using scenario analysis with AI tools to evaluate management teams and uncover hidden key-person risks - How to identify when a $3–5M EBITDA company truly has a middle management layer—or is still founder-reliant For anyone investing in or buying small businesses, Christien’s approach provides a fresh lens on growth, alignment, and deal structuring. 🎥 Watch the full interview here → https://lnkd.in/ekfkaiej 🎧 Listen on Spotify: https://lnkd.in/e86Agx6V

33

8 Comments

HARPETH VENTURES ANNOUNCES INVESTMENT IN VENTEUR Harpeth Ventures Opportunity Fund (“Harpeth Ventures”) is pleased to announce its participation in Venteur’s recent $20 million Series A funding round. The round was led by Informed Ventures and American Family Ventures, with participation from Morgan Health, Ingeborg Investments, Catalyst by Wellstar, Plug and Play, Revelry Venture Partners, Houghton Street Ventures, and Techstars. San Francisco-based Venteur is the leading healthcare benefits technology company transforming how employers offer and manage health insurance through Individual Coverage Health Reimbursement Arrangements (ICHRAs). Venteur’s platform empowers employers to offer flexible, personalized health benefits by enabling employees to select individual plans that fit their unique needs. Through a combination of technology and concierge support, Venteur helps individuals navigate their healthcare options while driving improved outcomes and greater cost efficiency for employers. More information is available at Venteur.com. “We greatly appreciate Harpeth Ventures’ involvement from both a capital and relationship perspective,” said Stacy Edgar, Co-Founder and CEO of Venteur. “The Harpeth team has already been instrumental in several business development opportunities.” Added Chuck Byrge of Harpeth Ventures, “With our relationship-driven approach, we were fortunate to meet Stacy in early 2024 and have followed their growth closely. We couldn’t be more excited about their future and the tailwinds driving ICHRA adoption.”

56

7 Comments